Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 74 publications.

Fleming AD, Philip S, Goatman KA, Williams GJ, Olson JA, Sharp PF. Automated detection of exudates for diabetic retinopathy screening. Phys Med Biol. 2007 Dec 21;52(24):7385-96. doi: 10.1088/0031-9155/52/24/012

Talbird SE, Brogan AJ, Winiarski AP, Sander B. The cost-effectiveness of treating influenza-like illness with oseltamivir in the US. Poster presented at the 42nd Midyear Clinical Meeting of the American Society of Health-System Pharmacists; December 2007.

Ettinger AE, Candrilli SD, Davis KL, Manjunath R. Prevalence and cost impact of noncompliance with antiepileptic drugs in an elderly managed care population. Poster presented at the 61st Annual Meeting of the American Epilepsy Society; December 2007.

Davis KL, Manjunath R, Candrilli SD, Ettinger AB. Impact of compliance with antiepileptic drugs on risk of serious breakthrough seizure in an adult managed care population with epilepsy. Poster presented at the 61st Annual Meeting of the American Epilepsy Society; December 2007.

Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM. The cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care. 2007 Nov 1;30(11):2874-9.

Graham JB, Earnshaw SR, Castelli-Haley J, Oleen-Burkey M, Johnson KP. Cost-effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis in the presence of long-term clinical evidence. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 24, 2007. [abstract] Value Health. 2007 Nov; 10(6):A381.

Earnshaw SR. Pharmacoeconomics and decision analysis. Presented at the North Carolina State University; November 2007.

Leeuwenkamp O, Morlock R, Bell C, Brogan AJ, Mauskopf J. Costs and outcomes of atypical antipsychotics for the treatment of acute schizophrenia. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 24, 2007. [abstract] Value Health. 2007 Nov; 10(6):A301.

Iyer S, Candrilli SD, Davis KL. Patterns of opioid use, opioid-related side effects and resource utilization in cancer patients on chronic opioid therapy with constipation versus matched controls without constipation. Poster presented at the Scientific Symposium of the National Hospice and Palliative Care Organization; November 2007.

Marton J, Jackel J, Carson R, Rothermel C, Menzin J. Predictors of costs for skin and skin structure infections due to staphylococcus aureus using a managed-care perspective. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 2007. Dublin, Ireland. [abstract] Value Health. 2007 Nov; 10(6):A446.

Philip S, Fleming AD, Goatman KA, Fonseca S, McNamee P, Scotland GS, Prescott GJ, Sharp PF, Olson JA. The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol. 2007 Nov 1;91(11):1512-7. doi: 10.1136/bjo.2007.119453

Scotland GS, McNamee P, Philip S, Fleming AD, Goatman KA, Prescott GJ, Fonseca S, Sharp PF, Olson JA. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland. Br J Ophthalmol. 2007 Nov 1;91(11):1518-23. doi: 10.1136/bjo.2007.120972

Mitra D, Davis KL, Candrilli SD, Tortella BJ, Joshi AV. Inpatient costs and outcomes associated with pediatric traumatic injury in the United States by injury severity and trauma center designation. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 24, 2007.

Zyczynski TM, Beard SM, Earnshaw SR, McDade CL. Cost-effectiveness analysis of the use of iodixanol compared to iohexol in the United Kingdom. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 24, 2007.

Mitra D, Davis KL, Baran RW. Healthcare costs and clinical sequelae associated with constipation in a managed care population. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 2007.

Mitra D, Baran RW, Davis KL. Medical service and prescription drug charges before and after initial diagnosis among managed care patients with constipation. Poster presented at the Educational Conference of the Academy of Managed Care Pharmacy; October 2007.

Davis KL, Candrilli SD, Manjunath R. Adherence with antiepileptic drugs and associated impact on time to seizure in adolescents diagnosed with epilepsy. Poster presented at the Annual Meeting of the Child Neurology Society; October 2007.

Davis KL, Candrilli SD, Mitra D, Tortella BJ, Joshi AV. The effect of injury severity and trauma center designation on inpatient costs and outcomes in hospital admissions for traumatic injury in the United States. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 2007. Dublin, Ireland.

Wolowacz SE, Roskell N, Kelly S, Maciver FM, Brand CS. Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK. Pharmacoeconomics. 2007 Oct 1;25(10):863-79.

Candrilli SD, Davis KL, Kan HJ, Lucero MA, Rousculp MD. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J Diabetes Complications. 2007 Oct 1;21(5):306-14.

Candrilli SD, Kuznik A, Rudolph AE. The prevalence and overlap of select cardiovascular comorbidities among US adults with dyslipidemia, by lipid-lowering medication use. Poster presented at the Annual Meeting of the American College of Clinical Pharmacy; October 2007.

Candrilli SD, Kuznik A, Rudolph AE. The prevalence and overlap of select cardiovascular comorbidities among the US elderly with dyslipidemia, by lipid-lowering medication use. Poster presented at the Annual Meeting of the American College of Clinical Pharmacy; October 2007.

Candrilli SD, Iyer S, Davis KL. Impact of constipation on health care utilization and costs in patients on opioid therapy. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 2007. Dublin, Ireland.

Earnshaw SR, Graham CN, Ettinger B, Amonkar MM, Lynch NO, Middelhoven H. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates. Curr Med Res Opin. 2007 Oct 1;23(10):2517-29.

Earnshaw SR, Wilson MR, Blanchette C. Cost-effectiveness of salmeterol/fluticasone propionate in the treatment of COPD: estimating the annual number of exacerbations in chronic obstructive pulmonary disease. Poster presented at the Annual Meeting of the American College of Chest Physicians; October 2007.

Menzin J, Wygant G, Hauch O, Friedman M, Jackel J. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Poster presented at the Educational Conference of the Academy of Managed Care Pharmacy; October 2007.

Davis KL, Candrilli SD, Iyer S. Impact of constipation on resource utilization and costs in non-metastatic cancer patients on opioid therapy. Poster presented at the Annual Clinical Meeting of the American Academy of Pain Management; September 2007.

Earnshaw SR, Hicks K, Richter A, Honeycutt A. A linear programming model for allocating HIV prevention funds with state agencies: a pilot study. Health Care Manag Sci. 2007 Sep 1;10(3):239-52.

Earnshaw SR, Moride Y, Rochon S. Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada. Clin Ther. 2007 Sep 1;29(9):2096-106.

Earnshaw SR, McDade CL, Mangel AW, Baran RW. Cost-effectiveness of lubiprostone in a managed care population with chronic idiopathic constipation. Poster presented at the 2007 ACG Annual Meeting; September 2007. [abstract] Am J Gastroenterol. 2007 Sep; 102(S2):S449-50.

Earnshaw SR, Graham CN, Gasper S. Cost-effectiveness of anidulafungin therapy in confirmed candidemia and other forms of invasive candidiasis. Poster presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); September 2007.

Iyer S, Candrilli SD, Davis KL. Opioid use patterns, health care utilization, and costs in metastatic cancer patients on chronic opioid therapy with constipation compared to patients without constipation. Poster presented at the 14th European Cancer Conference; September 2007.

Menzin J, Jackel J, Friedman M, Perfect J, Langston A, Danna R, Papadopoulos G. Clinical and economic burden of invasive fungal infections among hospitalized patients: findings from a U.S. national database. O-1869. Poster presented at the 47th Intersciences Conference on Antimicrobial Agents and Chemotherapy Meeting of the American Society for Microbiology; September 2007.

Akashi-Ronquest N. The effect of marriage, divorce, and remarriage on children's academic performance. Poster presented at the Employee Training and Development Lecture; September 2007. Previously presented at the Western Economics Association Meeting.

Shih YCT, Mauskopf J, Borker R. A cost-effectiveness analysis of first-line controller therapies for persistent asthma. Pharmacoeconomics. 2007 Jul 1;25(7):577-90.

Hicks KA, Honeycutt A. A high cost to missing the mark: dealing with uncertainty in hiv prevention resource allocation. Poster presented at the Informs International Conference; July 2007.

Rubino A, Rousculp MD, Davis KL, Wang J, Girach A. Diagnosed diabetic retinopathy in France, Italy, Spain, and the United Kingdom. Prim Care Diabetes. 2007 Jun;1(2):75-80.

Lynch NO, Earnshaw SR, Graham CN, Patroe V, Boisdron J, Middelhoven H. Ibandronate IV injection is cost-effective in the treatment of UK women with postmenopausal osteoporosis who are intolerant to oral bisphosphonates. Poster presented at the European League Against Rheumatism (EULAR) 2007 Annual European Congress of Rheumatology; June 2007.

Mauskopf J, Brogan AJ, Malmberg C, Hwang P. Cost-effectiveness of darunavir for the management of HIV-infected, treatment-experienced adults in Canada. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. Previously presented at the 16th Annual Canadian Conference on HIV/AIDS Research.

Mauskopf JA, Brogan AJ, Malmberg C, Hwang P. A Canadian cost-effectiveness analysis of darunavir for HIV infection in treatment-experienced adults. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 2007. Arlington, VA. [abstract] Value Health. 2007 May; 10(3):A163.

Candrilli S, Davis KL, Mitra D, Tortella BJ, Joshi AV. Inpatient costs and outcomes associated with traumatic injury in the United States by injury severity and trauma center designation. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(3):A97.

Mitra D, Davis KL, Baran R. Health care utilization and costs associated with constipation (C-ONLY) and co-occurring irritable bowel syndrome and constipation (IBS+C) compared to migraine in a large managed care population. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(3):A148-9.

Mitra D, Davis KL, Baran RW. Healthcare utilization and costs associated with constipation and co-occurring irritable bowel syndrome and constipation compared to matched controls in a large managed care population. Poster presented at the 2007 Digestive Disease Week; May 2007.

Javitt JC, Wolowacz SE, Roskell NS, Maciver F, Pleil A, Zlateva G. Balancing visual acuity benefits with systemic adverse effects in anti-VEGF therapy. Poster presented at the ARVO 9th Annual Meeting; May 2007; May 2007. Fort Lauderdale, FL.

Earnshaw SR, Wilson MR, Joshi AV. Cost-effectiveness of recombinant activated factor vii in the treatment of intracerebral hemorrhage over a two-year managed care enrollment period. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(2):A182. Previously presented at the 2006 International Stroke Conference.

Earnshaw SR, Okazawa M, Wilson MR, Blanchette C. Estimating the annual number of exacerbations in chronic obstructive pulmonary disease. Poster presented at the International Conference of the American Thoracic Society; May 2007.

Brogan AJ, Mauskopf JA, Martin S, Smets E. Cost-effectiveness analysis of darunavir/r for HIV infection in treatment-experienced adults in the US: understanding the uncertainty in the estimates. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 2007. Arlington, VA.

Mahajan S, Davis KL, Minnich M, Northcutt A, Bell T. The direct and indirect economic costs of irritable bowel syndrome in a large US employer population. Poster presented at the 2007 Digestive Disease Week; May 2007.

Mauskopf J, Brogan AJ, Malmberg C, Hwang P. Cost-effectiveness of darunavir for the management of HIV-infected, treatment-experienced adults in Canada. Poster presented at the 16th Annual Canadian Conference on HIV/AIDS Research; April 29, 2007.

Davis KL, Candrilli SD, Edin HM. Prevalence and cost impact of nonadherence with antiepilepsy drugs among adults in a managed care population. Poster presented at the Academy of Managed Care Pharmacy 19th Annual Meeting Showcase; April 14, 2007.